ABBV · News · 20260806N

Outstanding Indebtedness

AbbVie Inc. · 2026-08-06 · Importance 64 · Surprise 42

AbbVie launched a $10 billion bond sale to finance its pending Apogee Therapeutics acquisition. Earlier reporting indicated the company was seeking to raise at least $8 billion in debt for the transaction. The debt financing will increase leverage to fund the approximately $10.9 billion acquisition.

Key facts

• TradingView lists AbbVie's bond ABBV6474383 with a coupon rate of 5.45% and a maturity date of September 15, 2038. source